Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CA9 | Q16790 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | F11 | P03951 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL252706 | 1.00 | CA12 (0.54) | CA12CA9CA1CA3CA4 | |
| SCHEMBL28299982 | 0.98 | CA12 (0.52) | CA12CA9CA1CA3CA4 | |
| SCHEMBL3368797 | 0.85 | CA12 (0.60) | CA12CA9CA1CA3CA4 | |
| SCHEMBL25903990 | 0.79 | GAA (0.50) | CA12CA9CA1CA3CA4 | |
| SCHEMBL25904005 | 0.79 | CDK4 (0.50) | CA12CA9CA1CA3CA4 | |
| SCHEMBL4288324 | 0.78 | CA12 (0.52) | CA12CA9CA1CA3CA4 | |
| SCHEMBL31741308 | 0.77 | HRH4 (0.39) | CA12CA9CA1CA3CA4 | |
| SCHEMBL17951770 | 0.77 | MAPK1 (0.68) | CA12CA9CA1CA3CA4 | |
| SCHEMBL4290533 | 0.75 | CA12 (0.53) | CA12CA9CA1CA3CA4 | |
| SCHEMBL708122 | 0.74 | DAO (0.56) | CA12CA9CA1CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119470715-A | Method for determining impurity compound I and impurity compound II in key material of bripiprazole | 宁波大红鹰药业股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118580229-B | Preparation method of bripiprazole | 湖南一格制药有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118580229-A | Preparation method of bripiprazole | 湖南一格制药有限公司 | 2024-09-03 | — | — | CN | claimed |
| CN-114181202-A | Preparation method of brexpiprazole | 湖南省湘中制药有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-121735928-A | Brexperiment Process for preparing azoles | 浙江工业大学 | 2026-03-27 | — | — | CN | disclosed |
| CN-121081468-A | Application of 7-hydroxy-2 (1H) -quinolinone difluoro ethyl acetate-containing derivative in preparation of anti-triple negative breast cancer drugs | 遵义医科大学 | 2025-12-09 | — | — | CN | disclosed |
| CN-121059606-A | Antitumor application of 7-hydroxy-2 (1H) -quinolinone trifluoromethyl-containing derivative | 遵义医科大学 | 2025-12-05 | — | — | CN | disclosed |
| CN-121059606-A | Antitumor application of 7-hydroxy-2 (1H) -quinolinone trifluoromethyl-containing derivative | 遵义医科大学 | 2025-12-05 | — | — | CN | disclosed |
| CN-119462586-B | Coumarin derivative and application thereof | 安徽中医药大学 | 2025-05-06 | — | — | CN | disclosed |
| CN-119462500-A | Preparation method of 7- (4-chlorobutoxy) -1H-quinolin-2-one | 湖南省湘中制药有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462586-A | Coumarin derivative and application thereof | 安徽中医药大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119470715-A | Method for determining impurity compound I and impurity compound II in key material of bripiprazole | 宁波大红鹰药业股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-117986244-A | Quinolinone derivative and preparation method and application thereof | 江苏恩华药业股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117769545-A | Tri-fused ring derivative-containing regulator, preparation method and application thereof | 上海枢境生物科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117384129-A | Impurity compound, preparation method and application thereof | 浙江九洲药业股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-114835709-B | Azaergoline derivative, and preparation method and application thereof | 上海科技大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-115521298-A | Preparation method of brexpiprazole | 江苏慧聚药业股份有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-115279756-A | METTL3 modulators | 埃克森特治疗公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-114835709-A | Aza-ergoline derivative and preparation method and application thereof | 上海科技大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-114181202-A | Preparation method of brexpiprazole | 湖南省湘中制药有限公司 | 2022-03-15 | — | — | CN | disclosed |